HHS: Health Care Programs: Fraud and Abuse; Revisions to the Office of Inspector General's Exclusion Authorities
Source
Federal Register
Link
Date
Dec 2, 2024
Summary
Notice of proposed rule from the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) that would codify changes made by the Medicaid Services Investment and Accountability Act of 2019 (MSIAA), which added exclusion authorities related to misclassification and false information about outpatient drugs. This proposed rule would also update and clarify OIG's procedures for excluding individuals and entities from participation in the federal healthcare programs, including the factors that will be considered in determining the length of exclusions, the provisions governing notices of exclusions, and certain provisions related to reinstatement into the programs. Comments are due by January 31, 2025.
Tagged as
Health insurance · Legislation and regulations · Medicaid · Outpatient care · Pharmacy and prescription drugs